ArticleBlood advances2022

HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh.

Shanmuganathan Chandrakasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.